Different genetic susceptibility to aberrant crypts and colon adenomas in mice

Cancer Research

Volumn 56, Issue 10, 1996, Pages 2382-2386

  Moen, Corina J A ^a   Van Der Valk, Martin A ^a   Bird, Ranjana P ^b   Hart, Augustinus A M ^a   Demant, Peter ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIMETHYLHYDRAZINE; CARCINOGEN;

ANIMAL MODEL; ARTICLE; COLON ADENOMA; COLON CARCINOGENESIS; FEMALE; GENETIC SUSCEPTIBILITY; INBRED STRAIN; INTESTINE CRYPT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR LOCALIZATION;

1,2-DIMETHYLHYDRAZINE; ADENOMA; ANIMALS; CARCINOGENS; COLONIC DISEASES; COLONIC NEOPLASMS; CROSSES, GENETIC; DIMETHYLHYDRAZINES; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; FEMALE; GENES, APC; GENES, RAS; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; PRECANCEROUS CONDITIONS;

EID: 0029943905     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Kinsella, A Epidemiology and aetiology In: M M. Coombs, J Ashby, R M Hicks, and H Baxter (eds.), Colorectal Cancer: A Scientific Perspective, pp 27-53. Cambridge, United Kingdom Cambridge University Press, 1993.
2. Bird, R. P Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett., 37. 147-151, 1987.
3. McLellan, E. A., and Bird, R. P. Specificity study to evaluate induction of aberrant crypts in murine colons. Cancer Res., 48: 6183-6186, 1988.
4. McLellan, E. A , and Bird, R. P. Aberrant crypts: potential preneoplastic lesions in the murine colon. Cancer Res., 48: 6187-6192, 1988.
5. Sandforth, F., Heimpel, S., Baltzer, T., Gutschmidt, S., and Riecken, E. O. Characterization of stereomicroscopically identified preneoplastic lesions during dimethylhydrazine-induced colonic carcinogenesis Eur. J. Clin. Invest., 18: 655-662, 1988
6. Bird, R. P. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett , 93: 55-71, 1995.
7. Pretlow, T. P., Barrow, B. J., Ashton, W. S., O'Riordan, M A , Pretlow, T. G., Jurcisek, J. A., and Stellato, T. A. Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res., 51: 1564-1567, 1991.
8. Roncucci, L., Stamp, D., Medline, A., Cullen, J B., and Bruce, W R. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum. Pathol., 22: 287-294, 1991
9. Jen, J., Powell, S. M , Papadopoulos, N , Smith, K. J., Hamilton, S. R., Vogelstein, B., and Kinzler, K. W. Molecular determinants of dysplasia in colorectal lesions. Cancer Res., 54: 5523-5526, 1994.
10. Smith, A. J., Stern, H. S., Penner, M., Hay, K., Mitri, A , Bapat, B. V., and Gallinger, S. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res , 54: 5527-5530, 1994.
11. Fearon, E. R., and Jones, P. A. Progressing towards a molecular description of colorectal cancer. FASEB J., 6: 2783-2790, 1992.
12. Wiebecke, B., Löhrs, U., Gimmy, J., and Eder, M. Erzeugung von darmtumoren bei mäusen durch 1,2-dimethylhydrazin. Z. Gesamte Exp. Med., 149: 277-278, 1969.
13. Diwan, B. A., Meier, H., and Blackman, K. E. Genetic differences in the induction of colorectal tumors by 1,2-dimethylhydrazine in inbred mice. J. Natl. Cancer Inst., 59: 455-458, 1977.
14. Diwan, B. A., and Blackman, K E. Differential susceptibility of 3 sublines of C57B1/6 mice to the induction of colorectal tumors by 1,2-dimethylhydrazine. Cancer Lett , 9. 111-115, 1980.
15. Fleiszer, D., Hilgers, J , and Skamene, E. Multigenic control of colon carcinogenesis in mice treated with 1,2-dimethylhydrazine. Curr. Top Microbiol. Immunol., 137: 243-249, 1988.
16. Demant, P., and Hart, A. A. M. Recombinant congenic strains - a new tool for analyzing genetic traits determined by more than one gene. Immunogenetics, 24: 416-422, 1986.
17. Moen, C J A., van der Valk, M. A., Snoek, M , van Zutphen, L. F. M., von Deimling, O., Hart, A. A M , and Demant, P. The recombinant congenic strains - a novel tool applied to the study of colon tumor development in the mouse. Mamm. Genome, 1: 217-227, 1991.
18. Groot, P. C., Moen, C J A., Dietrich, W., Stoye, J. P., Lander, E. S., and Demant, P. The recombinant congenic strains for analysis of multigenic traits: genetic composition. FASEB J., 6: 2826-2835, 1992.
19. Groot, P C., Moen, C. J. A., Hart, A A M., Snoek, M., and Demant, P. Recombinant congenic strains - genetic composition. In: M. F. Lyon, S. Rastan, and S. D. M. Brown (eds.), Genetic Variants and Strains of the Laboratory Mouse. Ed. 3, pp. 1660-1670. Oxford, United Kingdom: Oxford University Press, 1996.
20. Stassen, A. P. M., Groot, P. C., Eppig, J. T., and Demant, P. Genetic composition of the recombinant congenic strains. Mamm. Genome, 7: 55-58, 1996
21. Harrison, P. T. C. An ethanol-acetic acid formol saline fixative for routine use with special application to the fixation of non-perfused rat lung. Lab. Anim., 18: 325-331, 1984.
22. Wright, S. P Adjusted P-values for simultaneous inference. Biometrics, 48: 1005-1013, 1992.
23. Carter, J. W , Lancaster, H. K., Hardman, W. E., and Cameron I. L. Distribution of intestine-associated lymphoid tissue, aberrant crypt foci, and tumors in the large bowel of 1,2-dimethylhydrazine-treated mice. Cancer Res., 54: 4304-4307, 1994.
24. Moen, C J. A., Snoek, M., Hart, A. A M., and Demant, P. SccI, a novel colon cancer susceptibility gene in the mouse - linkage to Cd44 (Ly24. Pgp1) on chromosome 2. Oncogene, 7: 563-566, 1992.
25. Moen, C. J. A., Groot, P. C., Hart, A. A. M., Snoek, M., and Demant, P. Fine mapping of colon tumor susceptibility (Stc) genes in the mouse, different from the genes known to be somatically mutated in colon cancer. Proc. Natl. Acad. Sci. USA, 93. 1082-1086, 1996.
26. Rosenberg, D. W , and Liu, Y. Identification of aberrant crypts in murine colon with varying sensitivity to colon carcinogenesis. Cancer Lett., 92. 209-214, 1995.